United Kingdom
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 6.54 B
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
2 |
USD 5.86 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
3 |
USD 526.42 M
|
Dec. 31, 2023 | USD 14.81 | -2.31% |
|
United Kingdom |
|
4 |
USD 442.63 M
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
5 |
USD 370.70 M
|
Dec. 31, 2023 | USD 5.03 | -1.57% |
|
United Kingdom |
|
6 |
USD 343.59 M
|
Dec. 31, 2023 | USD 1.73 | -0.82% |
|
United Kingdom |
|
7 |
USD 271.77 M
|
Dec. 31, 2023 | USD 48.44 | 3.75% |
|
United Kingdom |
|
8 |
USD 239.57 M
|
Dec. 31, 2023 | USD 2.21 | -3.91% |
|
United Kingdom |
|
9 |
USD 142.09 M
|
Dec. 31, 2023 | USD 0.95 | 0.80% |
|
United Kingdom |
|
10 |
USD 131.96 M
|
Dec. 31, 2023 | USD 4.79 | -4.31% |
|
United Kingdom |
|
11 |
USD 68.75 M
|
Dec. 31, 2023 | USD 5.61 | -4.92% |
|
United Kingdom |
|
12 |
USD 57.42 M
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
13 |
USD 53.79 M
|
June 30, 2024 | USD 17.38 | -3.70% |
|
United Kingdom |
|
14 |
USD 41.77 M
|
Dec. 31, 2023 | USD 5.68 | 0.09% |
|
United Kingdom |
|
15 |
USD 30.88 M
|
Sept. 30, 2024 | USD 0.36 | 3.24% |
|
United Kingdom |
|
16 |
USD 28.23 M
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
17 |
USD 25.32 M
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
18 |
USD 23.54 M
|
Dec. 31, 2023 | USD 0.23 | 1.46% |
|
United Kingdom |
|
19 |
USD 21.92 M
|
Dec. 31, 2023 | USD 1.04 | 1.96% |
|
United Kingdom |
|
20 |
USD 21.16 M
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
21 |
USD 20.63 M
|
Dec. 31, 2023 | USD 0.14 | 0.09% |
|
United Kingdom |
|
22 |
USD 16.35 M
|
June 30, 2024 | USD 0.09 | 2.54% |
|
United Kingdom |
|
23 |
USD 8.59 M
|
Dec. 31, 2023 | USD 0.71 | 0.09% |
|
United Kingdom |
|
24 |
USD 7.66 M
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
25 |
USD 7.60 M
|
Dec. 31, 2023 | USD 4.18 | -2.79% |
|
United Kingdom |
|
26 |
USD 6.41 M
|
Sept. 30, 2023 | USD 0.01 | -33.27% |
|
United Kingdom |
|
27 |
USD 4.96 M
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
28 |
USD 4.92 M
|
Sept. 30, 2023 | USD 0.14 | 0.09% |
|
United Kingdom |
|
29 |
USD 4.65 M
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
30 |
USD 4.11 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
31 |
USD 4.07 M
|
Aug. 31, 2023 | USD 0.16 | -0.68% |
|
United Kingdom |
|
32 |
USD 3.90 M
|
Dec. 31, 2023 | USD 15.26 | 0.09% |
|
United Kingdom |
|
33 |
USD 3.59 M
|
March 31, 2024 | USD 2.29 | -3.78% |
|
United Kingdom |
|
34 |
USD 3.21 M
|
Dec. 31, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
35 |
USD 2.58 M
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
36 |
USD 1.82 M
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
37 |
USD 1.79 M
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
38 |
USD 1.60 M
|
Dec. 31, 2023 | USD 0.20 | 0.09% |
|
United Kingdom |
|
39 |
USD 1.24 M
|
Nov. 30, 2023 | USD 0.03 | 0.09% |
|
United Kingdom |
|
40 |
USD 1.01 M
|
June 30, 2024 | USD 0.19 | -3.04% |
|
United Kingdom |
|
41 |
USD 762.13 K
|
Dec. 31, 2023 | USD 0.05 | 0.09% |
|
United Kingdom |
The Biotechnology company in United Kingdom with the highest Cash and Short-Term Investments is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD 6.54 B.
The Biotechnology company in United Kingdom with the lowest Cash and Short-Term Investments is Biome Technologies plc (LSE: BIOM.L) at USD 762.13 K.
The top 10 Biotechnology companies in United Kingdom by Cash and Short-Term Investments are Roivant Sciences Ltd., AstraZeneca PLC, Bicycle Therapeutics plc, Immunocore Holdings plc, Clarivate Plc, Oxford Nanopore Technologies plc, Verona Pharma plc, Autolus Therapeutics plc, Barinthus Biotherapeutics plc and Oxford Biomedica plc.
The bottom 10 Biotechnology companies in United Kingdom by Cash and Short-Term Investments are Biome Technologies plc, SkinBioTherapeutics Plc, Light Science Technologies Holdings Plc, Celadon Pharmaceuticals Plc, SDI Group plc, Abingdon Health Plc, Proteome Sciences plc, GENinCode plc, Virax Biolabs Group Limited and 4basebio PLC.